Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuances
Ratios

Aytu Biopharma (AYTU) Leases (2019 - 2025)

Historic Leases for Aytu Biopharma (AYTU) over the last 7 years, with Q4 2025 value amounting to $959000.0.

  • Aytu Biopharma's Leases fell 1859.08% to $959000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $959000.0, marking a year-over-year decrease of 1859.08%. This contributed to the annual value of $1.1 million for FY2025, which is 2798.55% up from last year.
  • According to the latest figures from Q4 2025, Aytu Biopharma's Leases is $959000.0, which was down 1859.08% from $1.0 million recorded in Q3 2025.
  • Over the past 5 years, Aytu Biopharma's Leases peaked at $3.8 million during Q4 2021, and registered a low of $700000.0 during Q3 2023.
  • Over the past 5 years, Aytu Biopharma's median Leases value was $2.1 million (recorded in 2023), while the average stood at $2.2 million.
  • As far as peak fluctuations go, Aytu Biopharma's Leases skyrocketed by 113840.9% in 2021, and later crashed by 7647.85% in 2023.
  • Aytu Biopharma's Leases (Quarter) stood at $3.8 million in 2021, then crashed by 30.43% to $2.7 million in 2022, then decreased by 20.26% to $2.1 million in 2023, then plummeted by 44.77% to $1.2 million in 2024, then dropped by 18.59% to $959000.0 in 2025.
  • Its Leases was $959000.0 in Q4 2025, compared to $1.0 million in Q3 2025 and $1.1 million in Q2 2025.